Contenuto
Ti trovi in: HOME »Programmi, progetti e risultati »I progetti »PRIN - Programmi di ricerca di Rilevante Interesse Nazionale»Programma di ricercaINIZIO_TESTO_DA_INDICIZZARE
RESEARCH PROGRAM
italiano - inglese
Research Units
- Università degli Studi di BOLOGNA
MEDICINA CLINICA E BIOTECNOLOGIA APPLICATA
BOLOGNA(BO) - Università degli Studi di VERONA
SCIENZE BIOMEDICHE E CHIRURGICHE
VERONA(VR) - Università degli Studi di BOLOGNA
MEDICINA INTERNA E GASTROENTEROLOGIA
BOLOGNA(BO) - Università degli Studi di MESSINA
SCIENZE BIOCHIMICHE FISIOLOGICHE E DELLA NUTRIZIONE
MESSINA(ME)
Similar research programs:
- 1 - ADVANCED TOOLS OF MOLECULAR IMAGING AND GENETIC ENGINEERING TO STUDY DISTRIBUTION AND DYNAMICS OF CELL MAGNESIUM: NOVEL APPROACHES TO LINK MAGNESIUM HOMEOSTASIS AND CELL FUNCTIONS.
- 2 - Causes, consequences, and therapeutic aspects of hyperhomocysteinemia in uremia and in diabetes.
- 3 - BETA-AMYLOID PRODUCTION AND CLEARANCE IN PATIENTS WITH ALZHEIMER DISEASE AND MILD COGNITIVE IMPAIRMENT: IN VITRO STUDIES AND EX VIVO MARKERS
- 4 - Pathophysiology, clinical aspects and therapy of adenocortical tumors.
- 5 - TISSUTAL METABOLISM AND GENIC EXPRESSION: NEWS PERSPECTIVES IN SURGERY
- 6 - Biochemical and genetic studies of autistic disorder
- 7 - Molecular and biochemical characterization of von Willebrand Factor and ADAMTS-13 interaction: new hypothesis on pathophysiology of thrombotic microangiopathies
- 8 - Genomic and non genomic effects of DITPA (partial T3 analogue) on cardiac function, endothelium dependent vasodilation and metabolic profile in experimental animals and in patients affected by heart failure, with or without low-T3 syndrome.
- 9 - Studies on the molecular mechanisms of abnormal parathyroid proliferation and function, and identification and clinical use of molecular markers of sporadic and familial parathyroid cancer. New insights on the prevalence of skeletal, neuropsychological and metabolic manifestations of primary hyperparathyroidism, their relationship with calcium sensing receptor polymorphisms and course after parathyroidectomy.
- 10 - Calcium nephrolithiasis and associated bone disorders: study of the interaction between genetic and nutritional causes and of pathogenetic mechanisms
Scientific and education field classification
- Field: Scienze biologiche
- Field: Scienze mediche
International Patent Classification
- HUMAN NECESSITIES
- MEDICAL OR VETERINARY SCIENCE; HYGIENE
- DIAGNOSIS; SURGERY; IDENTIFICATION (analysing biological material G01N, e.g. G01N33/48; obtaining records using waves other than optical waves, in general G03B42/00)
- ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY (measurement of bio-electric currents A61B; electrosurgical apparatus or circuits therefor A61B17/36; physical therapy arrangements in general A61H; anaesthetic apparatus in general A61M; incandescent lamps H01K; infra-red radiators for heating H05B)
- PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES (bringing into special physical form A61J [N: mechanical aspects]; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; compounds per se C01, C07, C08, C12N; soap compositions C11D; micro-organisms per se C12N) [C0203]
- MEDICAL OR VETERINARY SCIENCE; HYGIENE
Geographical classification
- Region: Emilia Romagna
Keywords
MAGNESIUM; CANALOPATHIES; LQT SYNDROME; CHRONIC INTESTINAL FAILURE; HOME PARENTERERAL NUTRITION; ALDOSTERONISM; 31 P MRS; CYTOFLUORIMETRYMagnesium Homeostasis in pathologies with primary and secondary defects of ion metabolism
Università degli Studi di BolognaAbstract
Mechanisms which regulate magnesium homeostasis in different tissues, are still not completely understood. Most studies report data about the total serum magnesium concentration, while is well known the intracellular free fraction to be that functionally important. This research project will contribute to the knowledge of the regulatory mechanism of magnesium homeostasis by assessing its distribution in several tissues in humans, by measuring the intracellular free concentration in skeletal muscle, brain, blood cells, and the total and free concentration in plasma. We will use analytical methods specific for each cell type investigated: phosphorus magnetic resonance spectroscopy (31P MRS) to measure in vivo intracellular free magnesium concentration in skeletal muscle and brain, fluorimetry and cytofluorimetry to measure intracellular free magnesium concentration in blood cells, atomic absorption and Mg-selective electrode to measure in plasma total and free concentration respectively. It is well known that the intracellular Mg2+ content changes in many pathologies. These can be divided in two wide groups: a) pathologies with primary defect of ion metabolism, in which Mg transport is directly affected, as canalopathies; b) pathologies with secondary defect of ion metabolism involving alteration in hormonal regulation or absorption defects . This research project will study three pathologies representing an adequate in vivo experimental models for studying magnesium >>>Principal Investigator
Bruno BARBIROLI Università degli Studi di BOLOGNAResearch Objectives
This research project will contribute to the knowledge of the regulatory mechanism of magnesium homeostasis by assessing its distribution in several tissues in humans, by measuring the intracellular free concentration in skeletal muscle, brain, blood cells, and the total and free concentration in plasma. We will use analytical methods specific for each cell type investigated: phosphorus magnetic resonance spectroscopy (31P MRS) to measure in vivo intracellular free magnesium concentration in skeletal muscle and brain, fluorimetry and cytofluorimetry to measure intracellular free magnesium concentration in blood cells, atomic absorption and Mg-selective electrode to measure in plasma total and free concentration respectively. We will examine three pathologies representing an adequate in vivo experimental models for studying magnesium homeostasis, for which there is also a clinical interest in the functional evaluation of magnesium deficit. We choose to examine 14 patients affected by LQT syndrome enrolled by the research unit of "Dipartimento di Scienze Biochimiche, Fisiologiche e della Nutrizione-Università di Messina", 23 affected by primary or secondary aldosteronism enrolled by the research unit of "Dipartimento di Biomedica e Scienze Chirurgiche -Università di Verona", 12 affected by chronic intestinal failure enrolled by the research unit of "Medicina Interna, Centro Regionale di Riferimento per Insufficienza Intestinale Cronica Benigna -Università di Bologna" and 50 >>>First Results
At the end of the first phase of the project, a first set of results obtained by 31P MRS and by the other analytical techniques will be available, and the study of patients affected by primary aldosteronism will be completed. A database will be made containing data coming from the exams and analytical assays of the subjects examined which will allow to get preliminary information about magnesium tissue distribution. The assessment of the skeletal muscle intracellular free magnesium concentration obtained in different metabolic condition by 31P MRS together with the measure of the post exercise phosphocreatine kinetics, both in healthy subjects and patients, will give information on the influence of magnesium on muscle mitochondrial functionality. Useful indication for the functional characterisation of the examined samples and for flow cytometric protocols setting up will be provided by comparing the results obtained by flow cytometry and spectrofluorimetryThe database will be completed containing all data coming from all exams and analytical assays of all subjects which will allow to obtain a detailed figure of magnesium tissue distribution and information on the regulatory mechanism of this ion.Furthermore, the evaluation of tissue distribution of magnesium in the different pathologies will give pivotal indications on the opportunity of magnesium supplementation as therapeutic support for patient treatment putting the basis for the project of adequate clinical >>>



